Tradeline Inc. has published the Novartis-Penn Center for Advanced Cellular Therapies in their weekly e-newsletter. Their profile highlights unique project design components that help develop life-saving cancer therapies more efficiently than ever before.

The strategic layout and organization of lab equipment enables Penn Medicine and Novartis to reduce the process of creating the ‘hunter cells’ for one patient from one month to two weeks.

Read the full Tradeline feature here. 

Read more about the Novartis-Penn Center